Rising incidence of Pneumocystis jirovecii pneumonia suggests iatrogenic exposure of immune-compromised patients may be becoming a significant problem

J Med Microbiol. 2012 Jul;61(Pt 7):1009-1015. doi: 10.1099/jmm.0.043984-0. Epub 2012 Apr 19.

Abstract

Against a background of point-source outbreaks of Pneumocystis pneumonia (PCP) in renal transplant units in Europe, we undertook a retrospective 3 year observational review of PCP in Northern Ireland. This showed an unexpected increase in incidence, with a mortality rate of 30 %. Fifty-one cases were confirmed compared to 10 cases confirmed in the preceding 7 years. Where undiagnosed HIV infection had previously been the main risk factor for PCP, this was now equally matched by chemotherapy for haematological and non-haematological malignancy and immune suppression for a range of autoimmune conditions. Congenital immunodeficiency and transplantation were less common predisposing factors, but renal grafts also showed a rising incidence. Asymptomatic carriage was uncommon. At presentation both upper and lower respiratory samples were of equal use in establishing the diagnosis, and treatment resulted in rapid clearance. These data suggest the need for considering PCP in at-risk patients, reviewing its mode of acquisition and whether iatrogenic colonization is a treatable pre-condition.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Child
  • Child, Preschool
  • Cross Infection / epidemiology*
  • Cross Infection / microbiology
  • Cross Infection / mortality
  • Europe
  • Humans
  • Iatrogenic Disease / epidemiology*
  • Immunocompromised Host*
  • Incidence
  • Infant
  • Infant, Newborn
  • Male
  • Middle Aged
  • Northern Ireland / epidemiology
  • Pneumocystis carinii / isolation & purification*
  • Pneumonia, Pneumocystis / epidemiology*
  • Pneumonia, Pneumocystis / microbiology
  • Pneumonia, Pneumocystis / mortality
  • Retrospective Studies
  • Survival Analysis
  • Young Adult